On Friday, the FDA approved the at-home use of FluMist, allowing those who are hesitant about needles to access a potentially lifesaving nasal spray flu vaccine more easily.
This marks the first time parents can administer the vaccine to children, and adults can use it themselves outside of a healthcare facility, although a prescription will still be necessary. FluMist is expected to be available from online pharmacies by next fall.
AstraZeneca, the producer, plans to launch a FluMist Home website where users can complete a questionnaire reviewed by a pharmacist before the treatment is shipped directly to them. The nasal spray will also remain available for in-office use. The current cost for a dose is approximately $35 to $45, depending on insurance coverage.
Dr. Peter Marks, director of the FDA’s vaccine center, emphasized that this approval offers a convenient option for families to receive a safe and effective flu vaccine. The FDA required AstraZeneca to demonstrate that the instructions for at-home use were clear and feasible, concluding that they were, but recommending that caregivers administer the spray to children aged 2 to 17.
Dr. Abraar Karan, an infectious disease specialist, noted that logistical barriers often prevent people from getting vaccinated, including the need for appointments and recovery time. He believes that the new at-home option will reduce these barriers and encourage more people to get vaccinated before flu season begins.
The president of Cyprus reaffirmed his government's commitment to strengthening defense and security ties with the U.S., highlighting that his recent meeting with President Biden outlined ambitious steps for their already strong bilateral relations.
Democratic presidential candidate Kamala Harris campaigns in Michigan on Sunday while her Republican rival Donald Trump stops in three eastern battleground states just two days before elections
Democratic candidate Kamala Harris and Republican Donald Trump remain in a tight race in the country's seven battleground states
At a U.N. Security Council meeting, the U.S. warned Iran of severe consequences if it escalates aggression against Israel or U.S. forces, as tensions rise following recent Israeli airstrikes on Iranian sites.
U.S. stocks dip as election nears, with Trump and Harris in a tight race and investors bracing for Fed policy news.
UN Deputy Secretary-General Amina Mohammed urged fair policies for clean energy minerals, highlighting the need for equity, transparency, and environmental protection as demand soars worldwide.
Retailers like Walmart are using advanced weather data to shape local promotions and inventory, adjusting prices on seasonal items like sunscreen and winter gear. New tools help companies plan amid unpredictable weather patterns driven by climate change.
AstraZeneca’s new weight-loss pill, AZD5004, shows promise in early trials with tolerable side effects, advancing to Phase II studies focused on reducing obesity.
Ryanair has trimmed its passenger growth target for the year ending March 2026 from 215 million to 210 million due to Boeing delivery delays. Despite a reported after-tax profit of 1.79 billion euros, average fares dropped by 10% this year.
Democratic presidential candidate Kamala Harris campaigns in Michigan on Sunday while her Republican rival Donald Trump stops in three eastern battleground states just two days before elections
Democratic candidate Kamala Harris and Republican Donald Trump remain in a tight race in the country's seven battleground states
Ryanair has trimmed its passenger growth target for the year ending March 2026 from 215 million to 210 million due to Boeing delivery delays. Despite a reported after-tax profit of 1.79 billion euros, average fares dropped by 10% this year.
AstraZeneca’s new weight-loss pill, AZD5004, shows promise in early trials with tolerable side effects, advancing to Phase II studies focused on reducing obesity.
An analysis of U.S. health claims reveals that while GLP-1 drugs like Wegovy may aid weight loss, they significantly increase medical costs—rising to $18,507 annually—without reducing obesity-related health events, raising concerns for insurers and employers.
The CDC confirms bird flu in two Washington poultry workers and ruled out infections in Missouri healthcare staff.
UK government has confirmed that disposable vapes will be banned from sale starting June 2025
Germany has detected its first case of the new mpox variant, clade 1b, in a 33-year-old man.
U.S. stocks dip as election nears, with Trump and Harris in a tight race and investors bracing for Fed policy news.
UN Deputy Secretary-General Amina Mohammed urged fair policies for clean energy minerals, highlighting the need for equity, transparency, and environmental protection as demand soars worldwide.
Retailers like Walmart are using advanced weather data to shape local promotions and inventory, adjusting prices on seasonal items like sunscreen and winter gear. New tools help companies plan amid unpredictable weather patterns driven by climate change.
AstraZeneca’s new weight-loss pill, AZD5004, shows promise in early trials with tolerable side effects, advancing to Phase II studies focused on reducing obesity.
Ryanair has trimmed its passenger growth target for the year ending March 2026 from 215 million to 210 million due to Boeing delivery delays. Despite a reported after-tax profit of 1.79 billion euros, average fares dropped by 10% this year.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment